Clinical Trial

Phase-Aligned Atrial Fibrillation Mapping

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Cardiac arrhythmia in the upper chamber of the heart (atrial fibrillation) can be cured by burning. Physicians burn very small pieces of abnormal tissue. It is important to know where to burn. The investigators propose a new way to find out where to burn. The investigators will use a new way to analyze electrical signals inside the heart and build a new electric map. The study may lead to the development of new technology. In the future, novel technology may increase the success rate and the number of cured atrial fibrillation patients. This study is a retrospective study of data collected during routine clinical care: atrial fibrillation ablations. The investigators will compare intracardiac electrograms and atrial activation maps in patients who had successful ablation outcomes (no recurrence within 1 year) and those who experienced a recurrence of arrhythmia within 1 year after the procedure.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-08-16 -> 2027-03-31 2026-07-02
minor Completion pushed: 2026-08-16 -> 2028-03-31 2026-07-02
Trial Details
NCT Number NCT06892561
Lead Sponsor Larisa Tereshchenko, MD, PhD
Collaborators: American Heart Association
Conditions Atrial Fibrillation (AF)
Enrollment 336 participants
Start Date 2023-08-16
Primary Completion 2027-03-31 (estimated)
Study Completion 2028-03-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-01